Drug name - Amturnide
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8183295 | NOVARTIS | Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
May, 2023
(7 months from now) | |
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 150MG BASE;EQ 5MG BASE;12.5MG | TABLET;ORAL | Discontinued |
| EQ 300MG BASE;EQ 5MG BASE;12.5MG | TABLET;ORAL | Discontinued |
| EQ 300MG BASE;EQ 5MG BASE;25MG | TABLET;ORAL | Discontinued |
| EQ 300MG BASE;EQ 10MG BASE;12.5MG | TABLET;ORAL | Discontinued |
| EQ 300MG BASE;EQ 10MG BASE;25MG | TABLET;ORAL | Discontinued |
availability in other generic markets.
Click on the highlighted region to filter.